Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Original Article

  • You have access
    Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
    Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
    Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  • You have access
    FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
    Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
    Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  • You have access
    Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
    Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
    Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  • You have access
    LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
    Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
    Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  • You have access
    Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
    Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
    Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  • You have access
    Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
    Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
    Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  • You have access
    Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
    Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
    Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  • You have access
    NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
    Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
    Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  • You have access
    The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
    Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
    Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  • You have access
    Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
    Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
    Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 37

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire